| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.fortismalar.com | |
| Market Cap | 94.83 Cr. | |
| Enterprise Value(EV) | 80.29 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -4.77 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 46.11 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 38.21 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 1.32 | Calculated using Price: 50.60 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.87 Cr. | 18,741,759 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder's vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care. | ||
| 1 Day |
|
-0.99% |
| 1 Week |
|
+1.25% |
| 1 Month |
|
-2.43% |
| 3 Month |
|
-13.47% |
| 6 Month |
|
-13.32% |
| 1 Year |
|
-14.07% |
| 2 Year |
|
-10.54% |
| 5 Year |
|
-13.84% |
| 10 Year |
|
+65.62% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 10.84 | 8.93 | 6.80 | 3.16 | 3.28 | 1.97 | -8.82 | -8.50 | -9.80 | |
| Return on Capital Employed (%) | 17.10 | 14.17 | 10.96 | 5.00 | 5.90 | 3.17 | -4.09 | -4.44 | -2.02 | |
| Return on Assets (%) | 9.13 | 6.85 | 4.97 | 2.40 | 2.40 | 1.39 | -5.27 | -4.51 | -5.29 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 85 | 91 | 98 | 100 | 103 | 105 | 96 | 89 | 80 | 73 | |
| Non Curr. Liab. | 1 | 0 | 0 | 0 | 0 | 0 | 56 | 47 | 41 | 41 | |
| Curr. Liab. | 16 | 37 | 32 | 30 | 45 | 44 | 36 | 25 | 31 | 35 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 101 | 128 | 130 | 130 | 148 | 149 | 188 | 161 | 152 | 149 | |
| Non Curr. Assets | 20 | 20 | 28 | 33 | 34 | 37 | 126 | 101 | 103 | 98 | |
| Curr. Assets | 82 | 108 | 102 | 97 | 113 | 112 | 62 | 60 | 49 | 51 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 101 | 128 | 130 | 130 | 148 | 149 | 188 | 161 | 152 | 149 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 108 | 118 | 130 | 141 | 149 | 145 | 112 | 69 | 86 | 88 | |
| Other Income | 7 | 8 | 9 | 8 | 8 | 10 | 11 | 8 | 7 | 6 | |
| Total Income | 115 | 126 | 138 | 149 | 158 | 155 | 123 | 78 | 94 | 94 | |
| Total Expenditure | -99 | -110 | -124 | -140 | -147 | -147 | -115 | -76 | -83 | -81 | |
| PBIDT | 16 | 15 | 14 | 9 | 10 | 8 | 8 | 2 | 11 | 13 | |
| Interest | 0 | -1 | 0 | 0 | 0 | -1 | -8 | -7 | -7 | -6 | |
| Depreciation | -2 | -3 | -3 | -4 | -4 | -4 | -13 | -13 | -13 | -12 | |
| Taxation | -5 | -4 | -4 | -1 | -2 | -1 | 3 | 3 | 0 | -4 | |
| Exceptional Items | -1 | 7 | |||||||||
| PAT | 9 | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -9 | |
| Minority Interest | |||||||||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 9 | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -9 | |
| Adjusted EPS | 5 | 4 | 3 | 2 | 2 | 1 | -5 | -4 | -4 | -5 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -64 | 5 | 4 | 10 | -9 | 9 | -16 | 0 | -1 | 7 | |
| Cash Fr. Inv. | 73 | -1 | 5 | -22 | 13 | -2 | 6 | 50 | -28 | 8 | |
| Cash Fr. Finan. | -7 | -1 | -1 | -1 | 0 | 0 | -12 | -7 | -10 | ||
| Net Change | 2 | 3 | 10 | -13 | 4 | 7 | -9 | 38 | -36 | 5 | |
| Cash & Cash Eqvt | 3 | 6 | 16 | 3 | 7 | 15 | 5 | 43 | 7 | 12 |
|
Mon, 20 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the Company is in receipt of information regarding loss of share certificates/issuance of duplicate share certificates as per the details mentioned in the enclosed letter. |
|
Mon, 27 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the Company is in the receipt of request for issuance of duplicate share certificate due to loss of certificates. |
|
Thu, 09 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of newspaper advertisements published on February 08 2023 in the columns of English daily Business Standard all editions and on Punjabi daily Rozana Spokesman Mohali edition with respect to un-audited financial results of the Company for the quarter and period ended on December 31 2022. |
| Tue, 21 Mar 2023 |
Opening at High
|
Close Within 52 Week Low Zone
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
CCI Bullish
|
Equities
M.F.
Sectors